Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-21 Sale |
2022-11-22 4:46 pm |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Director |
150,000 | $7.18 | $1,077,000 | 229,543 (Direct) |
View |
| 2022-02-24 Sale |
2022-02-25 4:54 pm |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
10,812 | $8.74 | $94,497 | 325,162 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 9:30 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
4,500 | $64.71 | $291,192 | 85,500 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-07 4:05 pm |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
11,220 | $20.68 | $232,030 | 414,620 (Indirect Direct) |
View |
| 2021-06-02 Sale |
2021-06-04 4:06 pm |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
23,000 | $17.33 | $398,590 | 225,104 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 6:14 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
4,000 | $76.09 | $304,360 | 90,000 (Direct) |
View |
| 2020-09-14 Sale |
2020-09-16 7:15 pm |
Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
47,861 | $27.19 | $1,301,253 | 425,087 (Direct) |
View |
| 2020-09-10 Sale |
2020-09-11 7:59 pm |
Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
27,128 | $26.08 | $707,581 | 554,444 (Direct) |
View |
| 2020-05-12 Sale |
2020-05-13 6:48 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
36,000 | $35.83 | $1,289,891 | 8,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-18 Option Award |
2024-12-20 6:04 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
16,733 | $22.99 | 131,490 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 3:55 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
14,987 | $25.41 | 114,754 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 8:32 pm |
2024-01-10 2033-01-10 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
12,460 | $0 | 104,360 (Direct) |
View |
| 2022-11-21 Exercise |
2022-11-22 4:46 pm |
N/A N/A |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Director |
150,000 | $5.99 | 229,543 (Direct) |
View |
| 2022-11-21 Exercise |
2022-11-22 4:46 pm |
2020-09-09 2022-11-27 |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Director |
150,000 | $0 | 229,543 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:15 pm |
2022-09-01 2031-12-22 |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
6,430 | $0 | 307,883 (Direct) |
View |
| 2022-06-01 Other |
2022-06-02 5:01 pm |
N/A N/A |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
23,754 | $0 | 321,712 (Direct) |
View |
| 2022-02-23 Option Award |
2022-02-25 4:54 pm |
2022-02-23 2031-12-22 |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
33,163 | $0 | 325,162 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 8:12 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
6,400 | $0 | 91,900 (Direct) |
View |
| 2021-12-22 Option Award |
2021-12-27 4:30 pm |
N/A 2031-12-22 |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
89,020 | $0 | 344,211 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-07 4:05 pm |
N/A N/A |
AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
23,754 | $0 | 414,620 (Direct) |
View |
| 2021-01-01 Option Award |
2021-01-05 6:14 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
9,000 | $0 | 90,000 (Direct) |
View |
| 2020-09-14 Option Award |
2020-09-16 7:15 pm |
N/A N/A |
Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
68,504 | $0 | 425,087 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 7:59 pm |
2020-09-09 2028-11-30 |
Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
108,333 | $0 | 554,444 (Direct) |
View |
Ownership |
2020-07-10 4:27 pm |
N/A N/A |
Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer |
0 | $0 | 473,239 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
25,000 | $4.2 | 335,000 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
5,000 | $2.01 | 335,000 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-18 6:27 pm |
2014-09-21 2023-09-21 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
77,000 | $0 | 335,000 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
7,000 | $4.75 | 335,000 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
15,000 | $5.19 | 335,000 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
10,000 | $2.62 | 335,000 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-18 6:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
15,000 | $2.19 | 335,000 (Direct) |
View |